Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Capacity Expansion

Gland Pharma Capacity Expansion

Gland Pharma announced a long-term strategic CDMO partnership with Neuland Laboratories to expand its sterile API manufacturing infrastructure at its Visakhapatnam facility.

Source

NSE filing, NSE: GLAND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Gland Pharma Ltd: key numbers

Share price
₹3,162.60
Market cap
₹52,186 Cr
Revenue (annual)
₹6,431 Cr
Net profit (annual)
₹1,027 Cr
P/E (TTM)
46.2×Sector 41.3×
Promoter holding
45.75%-6.02% QoQ
FII holding
10.36%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gland Pharma Ltd

All →
11:28 IST NSE
Regulatory Approval

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

Other capacity expansion announcements

All →
11:18 IST NSE
Capacity ExpansionSat Kartar Life Ltd SATKARTAR

Sat Kartar Life Capacity Expansion: ₹1.25 Cr Investment

Sat Kartar Life proposes a 30-bed Ayurveda hospital in Jaipur at an estimated ₹1.25 Crore investment. The facility is expected to be operational by March 2027.

Value
₹1.25 Cr
Ayurveda hospital beds
30 beds